EUVIMEDOpdag EUVIMED
Crossref

Beyond Cutaneous Injury: Immunopathogenesis, Early Recognition, and Therapeutic Challenges in DRESS and Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis

Ana Camila Subia Sandoval, Alberto Escamilla Huerta, Oscar Emmanuel Garcia Moreno, Javier Emanuel Camacho-Patiño, Velbeth Elizabeth Recinos Martínez, Omar Abdel Orellana Arévalo, Guillermo Andres Díaz León, José Rodrigo Roca Alvarez, Alvaro Enrique Marroquin Murcia

IECCMEXICO · 2026-10-30 · 5 (2)

DOI: 10.64784/367 ↗

At a glance

Journal article in IECCMEXICO, published online on 2026-10-30. Written by Ana Camila Subia Sandoval and 8 co-authors.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Severe cutaneous adverse drug reactions represent a major clinical challenge due to their complex immunological mechanisms, heterogeneous manifestations, and potential to cause life-threatening systemic complications. This narrative review examines the immunopathogenesis, early recognition, diagnostic assessment, and therapeutic management of drug reaction with eosinophilia and systemic symptoms (DRESS) and Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). Twenty scientific publications, including clinical investigations, systematic reviews, and international consensus recommendations, were analyzed through a qualitative synthesis incorporating contributions from Latin America. The findings revealed distinct patterns of immune-mediated injury, characterized by systemic inflammation, T-cell activation, and potential herpesvirus reactivation in DRESS, compared with cytotoxic keratinocyte destruction mediated by granulysin and other inflammatory pathways in SJS/TEN. Clinical evidence emphasized the relevance of early drug withdrawal, multidisciplinary assessment, and standardized instruments, including RegiSCAR, ALDEN, and SCORTEN. Therapeutic investigations identified potentially favorable outcomes associated with selected immunomodulatory interventions, including systemic corticosteroids, cyclosporine, and tumor necrosis factor-alpha inhibitors; however, methodological heterogeneity and limited randomized evidence restrict definitive conclusions regarding comparative effectiveness. Latin American contributions highlighted the importance of regional clinical guidelines and improved access to specialized care. Overall, integrating immunological knowledge with structured clinical assessment and evidence-based management may contribute to earlier recognition and more individualized care. Further multicenter investigations are required to clarify therapeutic effectiveness, identify reliable biomarkers, and improve long-term outcomes.

Cite

APA

Sandoval, A. C. S., Huerta, A. E., Moreno, O. E. G., Camacho-Patiño, J. E., Martínez, V. E. R., Arévalo, O. A. O., León, G. A. D., Alvarez, J. R. R., & Murcia, A. E. M. (2026). Beyond Cutaneous Injury: Immunopathogenesis, Early Recognition, and Therapeutic Challenges in DRESS and Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis. IECCMEXICO, 5(2). https://doi.org/10.64784/367

Vancouver

Sandoval ACS, Huerta AE, Moreno OEG, Camacho-Patiño JE, Martínez VER, Arévalo OAO, et al. Beyond Cutaneous Injury: Immunopathogenesis, Early Recognition, and Therapeutic Challenges in DRESS and Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis. IECCMEXICO. 2026;5(2). doi:10.64784/367

BibTeX
@article{Sandoval2026,
  author = {Sandoval, Ana Camila Subia and Huerta, Alberto Escamilla and Moreno, Oscar Emmanuel Garcia and Camacho-Patiño, Javier Emanuel and Martínez, Velbeth Elizabeth Recinos and Arévalo, Omar Abdel Orellana and León, Guillermo Andres Díaz and Alvarez, José Rodrigo Roca and Murcia, Alvaro Enrique Marroquin},
  title = {Beyond Cutaneous Injury: Immunopathogenesis, Early Recognition, and Therapeutic Challenges in DRESS and Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis},
  journal = {IECCMEXICO},
  year = {2026},
  volume = {5},
  number = {2},
  doi = {10.64784/367}
}
Start for free →